1. Home
  2. CE vs TFX Comparison

CE vs TFX Comparison

Compare CE & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celanese Corporation

CE

Celanese Corporation

HOLD

Current Price

$44.82

Market Cap

5.4B

Sector

Industrials

ML Signal

HOLD

Logo Teleflex Incorporated

TFX

Teleflex Incorporated

HOLD

Current Price

$134.40

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CE
TFX
Founded
1918
1943
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.8B
IPO Year
2004
1994

Fundamental Metrics

Financial Performance
Metric
CE
TFX
Price
$44.82
$134.40
Analyst Decision
Buy
Buy
Analyst Count
14
8
Target Price
$64.29
$138.75
AVG Volume (30 Days)
1.6M
390.5K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
0.18%
1.02%
EPS Growth
23.62
N/A
EPS
0.40
N/A
Revenue
$9,544,000,000.00
$1,992,713,000.00
Revenue This Year
$3.14
$15.97
Revenue Next Year
$2.83
$5.15
P/E Ratio
$113.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.13
$100.18
52 Week High
$70.70
$139.67

Technical Indicators

Market Signals
Indicator
CE
TFX
Relative Strength Index (RSI) 34.36 55.14
Support Level $43.14 $119.28
Resistance Level $49.32 $136.86
Average True Range (ATR) 1.74 4.19
MACD 0.06 0.27
Stochastic Oscillator 17.76 66.46

Price Performance

Historical Comparison
CE
TFX

About CE Celanese Corporation

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.

About TFX Teleflex Incorporated

Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.

Share on Social Networks: